27250949|t|Strategies for Assaying Lysosomal Membrane Permeabilization
27250949|a|Late endosomal organelles have an acidic pH and contain hydrolytic enzymes to degrade cargo delivered either from the extracellular environment by endocytosis or from within the cell itself by autophagy. In the event of lysosomal membrane permeabilization (LMP), the contents of late endosomes and lysosomes can be released into the cytosol and then initiate apoptosis. Compounds that can trigger LMP are therefore candidates for the induction of apoptosis, in particular in anticancer therapy. Alternatively, drug-delivery systems, such as nanoparticles, can have side effects that can include LMP, which has toxic consequences for the cells. To determine when, to what extent, and with what consequences LMP occurs is therefore of paramount importance for the evaluation of new potentially LMP - inducing compounds. In this introduction, we provide an overview of some basic assays for assessing LMP, such as staining with lysosomotropic dyes and measurement of cysteine cathepsin activity, and discuss additional strategies for the detection of the release of endogenous lysosomal molecules or preloaded exogenous tracers into the cytosol.
27250949	0	10	Strategies	T058	UMLS:C0184661
27250949	15	23	Assaying	T058	UMLS:C1510438
27250949	24	42	Lysosomal Membrane	T017	UMLS:C0230812
27250949	43	59	Permeabilization	T038	UMLS:C0007613
27250949	60	74	Late endosomal	T017	UMLS:C1166848
27250949	75	85	organelles	T017	UMLS:C0029219
27250949	116	134	hydrolytic enzymes	T103	UMLS:C0020289
27250949	178	191	extracellular	T017	UMLS:C0521119
27250949	192	203	environment	T082	UMLS:C0014406
27250949	207	218	endocytosis	T038	UMLS:C0014139
27250949	238	242	cell	T017	UMLS:C0007634
27250949	253	262	autophagy	T038	UMLS:C0004391
27250949	280	298	lysosomal membrane	T017	UMLS:C0230812
27250949	299	315	permeabilization	T038	UMLS:C0007613
27250949	317	320	LMP	T038	UMLS:C0007613
27250949	339	353	late endosomes	T017	UMLS:C1166848
27250949	358	367	lysosomes	T017	UMLS:C0024369
27250949	393	400	cytosol	T017	UMLS:C1383501
27250949	419	428	apoptosis	T038	UMLS:C0162638
27250949	457	460	LMP	T038	UMLS:C0007613
27250949	507	516	apoptosis	T038	UMLS:C0162638
27250949	535	553	anticancer therapy	T058	UMLS:C0920425
27250949	570	591	drug-delivery systems	T074	UMLS:C0085104
27250949	655	658	LMP	T038	UMLS:C0007613
27250949	670	688	toxic consequences	T037	UMLS:C0600688
27250949	697	702	cells	T017	UMLS:C0007634
27250949	766	769	LMP	T038	UMLS:C0007613
27250949	822	832	evaluation	T058	UMLS:C0220825
27250949	852	855	LMP	T038	UMLS:C0007613
27250949	931	943	basic assays	T058	UMLS:C1510438
27250949	958	961	LMP	T038	UMLS:C0007613
27250949	985	1004	lysosomotropic dyes	T103	UMLS:C0013343
27250949	1024	1032	cysteine	T103	UMLS:C0010654
27250949	1033	1042	cathepsin	T103	UMLS:C0007428
27250949	1043	1051	activity	T038	UMLS:C0243102
27250949	1076	1086	strategies	T058	UMLS:C0184661
27250949	1095	1104	detection	T058	UMLS:C1511790
27250949	1134	1143	lysosomal	T017	UMLS:C0024369
27250949	1177	1184	tracers	T103	UMLS:C1522485
27250949	1194	1201	cytosol	T017	UMLS:C1383501